AiViva Presenting at ATF 2026 Powered by Octane
AiViva BioPharma is pleased to join Octane Aesthetics Tech Forum this January 8–9, 2026 in Newport Beach as a Presenting Company. Diane Tang-Liu, CEO and President, is AiViva’s representative as well as Agustin de la Calle, Vice President of Business Development.
We look forward to discussions around AIV001, a clinical-stage dermatology program currently under evaluation in Phase I/IIa clinical studies.
In Phase I/IIa clinical studies, AIV001 is being evaluated as an investigational dermatology program in indications related to fresh and established scar modulation and exploratory approaches to surgical-free management of low-risk basal cell carcinoma (BCC), with assessments including safety, tolerability, histologic findings, and cosmetic outcomes.
Contact Agustin for appointments to meet with this dynamic duo: agustindlc@aiviva.com
https://www.octane-oc.org/event/atf2026/agenda